Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

UCB S.A. - SWOT, Strategy and Corporate Finance Report

UCB S.A.: Company Profile - New SWOT Analysis

UCB is a global biopharmaceutical company. The company focuses on severe diseases in the fields of central nervous system (CNS) disorders and autoimmune and inflammatory diseases (AIID). It has operations in about 40 countries in Europe, North America, Asia, Africa, Oceania and South America. It is headquartered in Brussels, Belgium and employed 8,898 people as of December 31, 2010. The company recorded revenues of E3,218 million ($4,269.3 million
) during the financial year (FY) ended December 2010, an increase of 3.3% over 2009. The operating profit of the company was E204 million ($270.6 million
) during FY2010, a decrease of 75.6% over 2009. The net profit was E103 million ($136.7 million
) in FY2010, a decrease of 79.9% over 2009.
Calculated using a constant conversion rate of E1 = $1.3267 for year ended December 31, 2010

Change Currency

GBP
USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings